Cargando…
HLA‐dependent variation in SARS‐CoV‐2 CD8 (+) T cell cross‐reactivity with human coronaviruses
The conditions and extent of cross‐protective immunity between severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) and common‐cold human coronaviruses (HCoVs) remain open despite several reports of pre‐existing T cell immunity to SARS‐CoV‐2 in individuals without prior exposure. Using a poo...
Autores principales: | Buckley, Paul R., Lee, Chloe H., Pereira Pinho, Mariana, Ottakandathil Babu, Rosana, Woo, Jeongmin, Antanaviciute, Agne, Simmons, Alison, Ogg, Graham, Koohy, Hashem |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9111820/ https://www.ncbi.nlm.nih.gov/pubmed/35143694 http://dx.doi.org/10.1111/imm.13451 |
Ejemplares similares
-
Potential CD8+ T Cell Cross-Reactivity Against SARS-CoV-2 Conferred by Other Coronavirus Strains
por: Lee, Chloe H., et al.
Publicado: (2020) -
A systems approach evaluating the impact of SARS-CoV-2 variant of concern mutations on CD8+ T cell responses
por: Buckley, Paul R, et al.
Publicado: (2023) -
A robust deep learning workflow to predict CD8 + T-cell epitopes
por: Lee, Chloe H., et al.
Publicado: (2023) -
Predicting Cross-Reactivity and Antigen Specificity of T Cell Receptors
por: Lee, Chloe H., et al.
Publicado: (2020) -
Evaluating performance of existing computational models in predicting CD8+ T cell pathogenic epitopes and cancer neoantigens
por: Buckley, Paul R, et al.
Publicado: (2022)